Otsuka Holdings Co., Ltd.
Research Otsuka Holdings Co., Ltd. (4578.T) on Bullrun: market cap JPY 6.46T, P/E 16.2, dividend yield 1.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4578.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryDrug Manufacturers - General
- CurrencyJPY
- Market capJPY 6.46T
- P/E16.2
- Dividend yield1.4%
- Financial periodFY2025
- RevenueJPY 2.47T
- Revenue growth6.0%
- Net incomeJPY 363.15B
- Free cash flowJPY 261.91B
- Gross margin71.7%
Valuation Snapshot
latest market cap is JPY 6.46T; P/E is 16.2; dividend yield is 1.4%.
Peer valuation comparison
Latest P/E is 16.16x versus a Healthcare sector median of 21.69x (25.5% below).
Latest dividend yield is 1.38% versus a Healthcare sector median of 2.41% (42.7% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | JPY 2.47T | JPY 363.15B | JPY 261.91B | 71.7% | 685.06 | JPY 534.65B | JPY 227.98B | JPY 3.03T |
| FY2024 | JPY 2.33T | JPY 343.12B | JPY 225.28B | 71.7% | 633.76 | JPY 426.17B | JPY 189.38B | JPY 2.73T |
| FY2023 | JPY 2.02T | JPY 121.62B | JPY 168.56B | 69.7% | 224.1 | JPY 513.34B | JPY 214.19B | JPY 2.39T |
| FY2022 | JPY 1.74T | JPY 133.91B | JPY 104.06B | 67.2% | 246.78 | JPY 471.63B | JPY 194.16B | JPY 2.23T |
| FY2021 | n/a | n/a | n/a | n/a | 231.15 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 6.46T | 16.2 | 1.6% | 200 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 200 JPY, yield 1.4%.
| Year | Dividends/share |
|---|---|
| FY2025 | 140 JPY |
| FY2024 | 120 JPY |
| FY2023 | 110 JPY |
| FY2022 | 100 JPY |
| FY2021 | 0.54 JPY |
About Otsuka Holdings Co., Ltd.
Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Otsuka Holdings Co., Ltd.'s market cap?
Otsuka Holdings Co., Ltd.'s market capitalization is JPY 6.46T.
What is Otsuka Holdings Co., Ltd.'s P/E ratio?
Otsuka Holdings Co., Ltd.'s price-to-earnings (P/E) ratio is 16.2.
Does Otsuka Holdings Co., Ltd. pay a dividend?
Otsuka Holdings Co., Ltd. has a dividend yield of 1.4%.
What does Otsuka Holdings Co., Ltd. do?
Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices.